CEL-SCI Competitors and Similar CompaniesClear all
CEL-SCI's competitors and similar companies include Topas Therapeutics, ONCOtherapeutics, Saniona and Elixiron Immunotherapeutics.
 CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Topas Therapeutics Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. |  ONCOtherapeutics ONCOtherapeutics is a contract research organization that runs multiple clinical trials. |  Saniona Saniona, a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. |  Elixiron Immunotherapeutics Elixiron Immunotherapeutics is a biotechnology company that develops therapies for immunological and degenerative diseases. | |
Founding Date | Founding Date 1983 | Founding Date 2013 | Founding Date 2005 | Founding Date 2011 | Founding Date 2017 |
Type | Type Public | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Vienna, US HQ | Locations Hamburg, DE HQ Bremen, DE | Locations West Hollywood, US HQ | Locations Ballerup, DK HQ Glostrup, DK Waltham, US | Locations TW HQ |
Employees | Employees N/A | Employees N/A | Employees 13 | Employees 22 | Employees 19 |
Valuation ($) | Valuation ($) 58.7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 42.9 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($25.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income kr284.7m (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 5m (over 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 27m (over 4 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 20.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 37.5m |
For sources of this data, please see the company profile
View Company Profiles
Topas Therapeutics
HQ
Hamburg, DE
Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis.
View companyONCOtherapeutics
HQ
West Hollywood, US
Employees
13
ONCOtherapeutics is a contract research organization that runs multiple clinical trials.
View companySaniona
HQ
Ballerup, DK
Employees
22
Saniona, a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain.
View companyElixiron Immunotherapeutics
HQ
TW
Employees
19
Elixiron Immunotherapeutics is a biotechnology company that develops therapies for immunological and degenerative diseases.
View company